Algo version: 0.98b
New Horizon Health is listed at the HKSE Exchange
New Horizon Health [6606.HK]
HKSE Sector: Industry:Diagnostics & Research

Is New Horizon Health stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

We cannot find any recorded dividends paid in our systems.

Sorry, we do not have any analyst data for this ticker

We cannot find data for New Horizon Health 10 years ago, but if you had invested on Thursday 18th of February 2021 when the price was $84.00, you would have made a loss of $-69.86 per share or -83.17%

We do not have enough data to give you this answer.

New Horizon Health has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. New Horizon Health has a good net profit margin of 10.86% and should have high tolerances against inflation.

We have calculated the inflation risk for New Horizon Health to be medium [0.55 of 1]

US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.